Drug
Bromocriptine clinical trials
Also written Cycloset and Parlodel.
- studies test it
- 28
- open now
- 2
- in phase 3
- 7
- first study started
- 1999
Keep track of what changes. Save the Bromocriptine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
28 studies that test it; most in 2013 (4)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 5
- Phase 2
- 7
- Phase 3
- 7
- Phase 4
- 6
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 23
VeroScience (3) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · Boehringer Ingelheim (2) · University Hospital Tuebingen (1) · Kyoto University (1) · University of California, San Diego (1) · Eastern Virginia Medical School (1) · University of Colorado, Denver (1)
Often tested with
Tested in the same studies.
Pramipexole (2) · Amisulpride (1) · Lactulose (1) · Rifaximin (1) · Rivaroxaban (1) · Methimazole (1) · Pentoxifylline (1) · Cabergoline (1)
Studies
Open first, then newest update. How each study uses Bromocriptine is read from its arms, and is right about nine times in ten.
Testing it · 28
- Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyRecruitingPhase 4Dennis M. McNamara, MD, MSNCT05180773Written as Bromocriptine
- Bromocriptine for Patients With Schizophrenia and PrediabetesNot yet recruitingPhase 4VA Pittsburgh Healthcare SystemNCT03575000Written as Bromocriptine
- Dopamine Action on Metabolism in Relation to GenotypeCompletedPhase 2University Hospital TuebingenNCT03525002Written as Bromocriptine
- Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's DiseaseCompletedPhase 1/2Kyoto UniversityNCT04413344Written as Bromocriptine Mesilate
- Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia NervosaCompletedEarly Phase 1University of California, San DiegoNCT04128683Written as bromocriptine
- Bromocriptine in the Treatment of Peripartum CardiomyopathyWithdrawnPhase 3Montreal Heart InstituteNCT02590601Written as Bromocriptine
- Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes SubjectsCompletedPhase 4Eastern Virginia Medical SchoolNCT02682901Written as Cycloset
- Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT InhibitorWithdrawnPhase 4University of California, BerkeleyNCT02929485Written as Bromocriptine
- Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 DiabetesCompletedPhase 2University of Colorado, DenverNCT02544321Written as Bromocriptine
- Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic InjuryCompletedPhase 1/2University of California, San FranciscoNCT03496545Written as Bromocriptine 5 MG
- Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum CardiomyopathyCompletedPhase 2Hannover Medical SchoolNCT00998556Written as Bromocriptine
- Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid ResponseCompletedPhase 2Ganin Fertility CenterNCT04351126Written as Bromocriptine
- Satisfaction of Patients With the Chosen Method of Inhibition of LactationStatus unknownNot applicableŻelazna Medical Centre, LLCNCT04038749Written as Bromocriptine
- Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue TherapyCompletedPhase 4The University of Texas Health Science Center at San AntonioNCT02299050Written as Cycloset
- Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DMEWithdrawnPhase 1/2Andrew Moshfeghi, MD, MBANCT03384524Written as Bromocriptine 2.5 MG
- Vaginal Bromocriptine for Treatment of AdenomyosisCompletedPhase 1Mayo ClinicNCT01821001Written as Vaginal Bromocriptine
- To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related ParkinsonismCompletedNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT02265484Written as Lactulose+Rifaximin +Bromocriptine
- Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus SubjectsCompletedPhase 1VeroScienceNCT02078440Written as Bromocriptine mesylate
- Safety and Tolerability Study of Cycloset in Treatment of Type 2 DiabetesCompletedPhase 3VeroScienceNCT00377676Written as Cycloset
- Bromocriptine and Insulin SensitivityCompletedNot applicableAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT02428946Written as Bromocriptine
See all 28 studies that test Bromocriptine →
Given in every arm · 1 — Bromocriptine is usual care beside what is tested
As the comparator · 6 — what is tested is compared with Bromocriptine
- A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate TabletsRecruitingPhase 3Changchun GeneScience Pharmaceutical Co., Ltd.NCT07124221Written as Bromocriptine mesylate tablets
- Surgical and Pharmacological Efficacy of Knosp Grade 0-2 ProlactinomaNot yet recruitingNot applicableSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT06556186Written as Bromocriptin 2.5mg, 2-3 times a day
- Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate TabletsCompletedPhase 1Mylan Pharmaceuticals IncNCT00650520Written as Parlodel® (bromocriptine mesylate) capsules, USP 5 mg
- Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00649168Written as Parlodel® (bromocriptine mesylate) capsules, USP 5 mg
- Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's DiseaseCompletedPhase 4SandozNCT01673724Written as Bromocriptine
- Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation SyndromeStatus unknownPhase 2Sun Yat-sen UniversityNCT02846493Written as bromocriptine
Codes
What other systems call Bromocriptine · ClinicalTrials.gg INT007090
- MeSH (NLM) D001971BromocriptineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 3A64E3G5ZOBROMOCRIPTINEConfirmed FDA, NLM, Wikidata
- RxNorm 1760Confirmed FDA, Wikidata
- Wikidata Q413581bromocriptineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C62010BromocriptineOne source FDA
- DrugBank DB01200One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D001971 | Bromocriptine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 3A64E3G5ZO | BROMOCRIPTINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1760 | — | Confirmed FDA, Wikidata |
| Wikidata | Q413581 | bromocriptine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C62010 | Bromocriptine | One source FDA |
| DrugBank | DB01200 | — | One source Wikidata |
Also registered as bromocriptine mesylate (UNII FFP983J3OD · RxNorm 142426).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.